Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy

详细信息    查看全文

• 作者：Jina Wu ; Ye Lin ; Huan Li ; Qiao Jin ; ^{jinqiao@zju.edu.cn" class="auth_mail" title="E-mail the corresponding author} ; Jian Ji
• 关键词：ALA ; Photodynamic therapy ; Zwitterionic ; Prodrug ; Nanocarrier
• 刊名：Journal of Colloid and Interface Science
• 出版年：2017
• 出版时间：1 January 2017
• 年：2017
• 卷：485
• 期：Complete
• 页码：251-259
• 全文大小：2675 K

文摘

5-Aminolevulinic acid (ALA) is a FDA-approved photodynamic therapy (PDT) precursor of protoporphyrin IX (PpIX) used for treating various cancers. However, the internalization of ALA is a big challenge due to its hydrophilic nature and low specificity to cancer cells. In this work, ALA conjugated prodrug nanoparticles were prepared by conjugation of thiolated stealth peptide sequence CPPPPEKEKEKEKEKEDGR and hydrazone-containing ALA to gold nanoparticles (AuNPs). Remarkable anti-fouling ability of ALA prodrug nanoparticles in complex environment was achieved owing to the zwitterionic stealth peptide sequence EKEKEKEKEK. The release of ALA could be greatly accelerated upon incubation of ALA prodrug nanoparticles in lysosomal/endosomal pH (pH 5.5). Meanwhile, the cellular internalization could be greatly enhanced by RGD moieties. MTT results demonstrated that ALA prodrug nanoparticles exhibited better photodynamic cytotoxicity than free ALA after light irradiation, suggesting enhanced photodynamic therapeutic efficacy.